NU 578 Unit 4 Study Guide Pharmacology for Advanced Practice Nurses Lehne's Pharmacology for Nursing Care (9 edition):Chapters 57-75, 78-82

UNIT 4: ENDOCRINE, ANTI-INFLAMMATORY, BONE
and JOINT, and GI PHARMACOLOGY


Pharmacology for Advanced Practice Nurses

Lehne’s Pharmacology for Nursing Care (9 th edition):
Chapters 57 – 75, 78 – 82




Edited by: Jessica Santos

,SECTION I: INDEX




QUESTION Page(s)
1. FAMILIARIZE YOURSELF WITH TSH LEVELS, WHAT LABS ARE
IMPORTANT, WHAT TO DO WHEN TSH IS LOW OR ELEVATED. (P. 7
705; KEY SEARCH TERM: “SERUM TSH SERUM”)
2. REVIEW HYPOTHYROIDISM IN NEONATES – HOW IS THIS
TREATED? (P. 706; KEY SEACH TERM: “HYPOTHYROIDISM IN 7–8
NEWBORNS”)
3. REVIEW DOSING IN ADULTS AND ELDERLY. (P. 709; KEY SEARCH
8
TERM: “ADULTS WHEN CALCULATED”)
4. WHAT DRUGS INTERACT WITH LEVOTHYROXINE – WHAT DO YOU
DO TO ADJUST THE MEDICATION? (P. 708; KEY SEARCH TERM: 8–9
“XENICAL TO ENSURE”)
5. PATIENT EDUCATION REGARDING PREGNANCY AND
HYPOTHYROIDISM. (P. 706; KEY SEARCH TERM: “MATERNAL 9
HYPOTHYROIDISM CAN”)
6. WHAT IS THE DIFFERENCE BETWEEN LEVOTHYROXINE
AND SYNTHROID? (P. 708; KEY SEARCH TERM: “POINT OF 9
CONTENTION”)
7. REVIEW PROPYLTHIOURACIL – INDICATIONS, SIDE EFFECTS,
PATIENT EDUCATION. (P. 710; KEY SEARCH TERM: 10
“PROPYLTHIOURACIL LIKE”)
8. MEDICATIONS FOR TREATMENTS, SIDE EFFECTS, APPROPRIATE
DOSAGE, DRUG INTERACTIONS, PATIENT TEACHING, DURATION OF 10 – 12
TREATMENT. (P. 706; KEY SEARCH TERM: “DISEASE GRAVES’”)
9. DRUGS USED, ADVERSE EFFECTS. (P. 706; KEY SEARCH TERM:
13
“WOMEN TAKING THYROID”)
10. ASSESSMENT FOR HYPO AND HYPERTHYROIDISM AS WELL AS
THYROID STORM—HOW IS THYROID STORM MANAGED? (P. 705; 14
KEY SEARCH TERM: “GO UNRECOGNIZED FOR WHAT”)
11. REVIEW ANTIEMETICS – UNDERSTAND HOW THESE MEDICATIONS
14 – 15
WORK. (P. 971; KEY SEARCH TERM: “ANTIEMETICS ARE GIVEN”)
12. WHICH DRUGS ARE USED, TESTS FOR DIAGNOSIS, PATIENT
EDUCATION, COST EFFECTIVE REGIMENS. (PP. 947, 955; KEY 15 – 17
SEARCH TERM: “THE MAJOR AGGRESSIVE”)



2

,13. WHAT ARE SOME ANTICIPATED SIDE EFFECTSS WHEN
DISCONTINUING LONG-TERM USE OF GERD MEDICATIONS. (P. 954; 18
KEY SEARCH TERM: “PREFERENCE ALTHOUGH”)
14. REVIEW MEDICATIONS FOR PEPTIC ULCER DISEASE. (P. 950; KEY
18 – 20
SEARCH TERM: “ANTIBACTERIAL DRUGS SHOULD”)
15. REVIEW ZOLLINGER-ELLISON SYNDROME. (PP. 948, 952; KEY
20
SEARCH TERM: “INVOLVED ZOLLINGER”)
16. REVIEW OBESITY MANAGEMENT DRUGS. (P. 998; KEY SEARCH
20 – 22
TERM: “WEIGHT LOSS DRUGS LIPASE”)
17. REVIEW ALL MEDICATIONS FOR CONSTIPATION, REVIEW PATIENT
EDUCATION INFORMATION – LENGTH OF TIME FOR RESOLUTION
23 – 26
BASED ON MEDICATION. (P. 963; KEY SEARCH TERM: “STIMULATE
DEFECATION THESE”)
18. REVIEW THE MEDICATIONS, DOSE, ROUTE. (P. 716; KEY SEARCH
26 – 28
TERM: “HORMONE GROWTH”)
19. WHAT ARE RISKS AND BENEFITS OF THESE DRUGS, WHAT ARE
SOME OF SIDE EFFECTS? (P. 718; KEY SEARCH TERM: “ELICITED 28 – 29
EFFICACY”)
20. REVIEW THE WOMEN’S HEALTH INITIATIVE (WHI)
RECOMMENDATIONS ON HORMONE REPLACEMENT THERAPY. (PP. 29
741, 744; KEY SEARCH TERM: “RESULTS OF TWO TRIALS”)
21. REVIEW INDICATIONS FOR USE OF INSULIN. (P. 681; KEY SEARCH
29
TERM: “MELLITUS INSULIN IS”)
22. REVIEW ALL SHORT-ACTING AND LONG-ACTING MEDICATIONS,
WHEN AND HOW TO USE, PATIENT EDUCATION. (P. 684; KEY
SEARCH TERM: “BIGUANIDES METFORMIN METFORMIN”) – PLEASE 29 – 31
SEE QUESTIONS #23 AND #24 FOR ADVERSE EFFECTS,
CONTRAINDICATIONS, AND DOSAGES
23. ADVERSE EFFECTS AND CONTRAINDICATIONS TO USE OF ORAL
ANTIDIABETICS. (P. 686; KEY SEARCH TERM: “INSUFFICIENCY 31
METFORMIN”)
24. DOSING OF ORAL ANTIDIABETICS—HOW AND WHEN DO PATIENTS
TAKE THESE FOR BEST EFFECT? (P. 686; KEY SEARCH TERM: 32 – 33
“BELOW WITH THE”)
25. MONITORING OF ORAL ANTIDIABETICS FOR SIDE EFFECTS—THINK
HYPOGLYCEMIA HERE. (P. 684, KEY SEARCH TERM: "SEVEN MAIN
34
FAMILIES") – PLEASE SEE THE TABLE UNDER QUESTION #23 FOR
ADDITIONAL INFORMATION
26. LAB VALUES PERTINENT TO CARE OF PATIENTS ON DIABETIC
MEDICATIONS (ORAL OR INSULIN)—AGAIN, THINK OF BG, HBA1C,
35
BUT ALSO ELECTROLYTES (K+ IN PARTICULAR). (P. 673; KEY
SEARCH TERM: "SMBG IS RECOMMENDED")
27. DURATION OF ACTION OF THE DIFFERENT INSULIN
PREPARATIONS. (PP. 677, 678; KEY SEARCH TERM: "CLASSIFIED 35 – 36
ACCORDING TO TIME")
28. DIABETIC PATIENT TEACHING; LIFESTYLE MODIFICATIONS FOR
36
DIABETIC PATIENTS. (P. 671; KEY SEARCH TERM: “MEASURES
PROPER”)
29. REVIEW DPP-INHIBITORS – SIDE EFFECTS, PATIENT EDUCATION. (P.
37
690; KEY SEARCH TERM: “GLIPTINS DPP”)
30. WHICH ANTI-HYPERTENSIVES WORK WELL WITH DIABETICS? (P.
37
669; KEY SEARCH TERM: “NEPHROPATHY THAT IS”)
31. TREATMENT OF POLYCYSTIC OVARY SYNDROME. (PP. 770; KEY
37
SEARCH TERM: “PCOS CAN BE TREATED”)
32. MAKE SURE YOU ARE FAMILIAR WITH PATIENT EDUCATION
REGARDING UTILIZATION OF DIABETES MEDS, DIRECTIONS FOR
38 – 40
TAKING MEDICATION, ETC. (P. 698; KEY SEARCH TERM: “PREPARE
FOR SUBQ”)
33. DIABETES MEDICATION IN PREGNANCY—WHICH ONES ARE
40
APPROVED FOR USAGE? (PP. 685, 670, 687-688; KEY SEARCH TERM:



3

, “PREGNANCY BEFORE THE”)
34. VITAMIN D DEFICIENCY – REVIEW PROTOCOLS FOR ADULTS AND
41 – 42
CHILDREN. (P. 900; KEY SEARCH TERM: “VITAMIN D THE TERM”)
35. ADDISON’S DISEASE - REVIEW ACTH AND COSYNTROPIN. (P. 728;
43
KEY SEARCH TERM: “CAUSES PRIMARY ADRENOCORTICAL”)
36. CUSHING’S SYNDROME, HYPERALDOSTERONISM. (PP. 727-728; KEY
43
SEARCH TERM: “EXCESS CUSHING’S”)
37. GROWTH HORMONE DEFICIENCY. (PP. 717-718; KEY SEARCH TERM:
44
“PEDIATRIC GH IS”)
38. REVIEW ADRENAL INSUFFICIENCY AND STRESS – WHAT SHOULD A
PATIENT DO WITH THEIR MEDS DURING TIMES OF STRESS? (P. 728; 44 – 45
KEY SEARCH TERM: “RECALL THAT HEALTHY”)
39. ADRENAL INSUFFICIENCY AND LONG-TERM STEROID USE –
RECOMMENDATIONS FOR SURGICAL PROCEDURES. (P. 728; KEY
45
SEARCH TERM: “MODERATE OPEN”) – PLEASE SEE QUESTION #38
FOR ADDITIONAL INFORMATION
40. SPECIFICALLY, CYCLOSPORINE AND PROGRAF. (PP. 834-836; KEY
45
SEARCH TERM: “CHOICE FOR PREVENTING ORGAN”)
41. HOW ARE THESE MONITORED. (PP. 835-836, 840; KEY SEARCH TERM:
46
“ALSO INDICATE REJECTION”)
42. WHAT DRUGS ARE CONTRAINDICATED WHEN USING
CYCLOSPORINE OR PROGRAF. (PP. 835-836, 840; KEY SEARCH TERM: 46 – 47
“BELOW DRUGS THAT CAN”)
43. VACCINATION CONTRAINDICATIONS. (P. 837, 840; KEY SEARCH
47
TERM: “VACCINES IN ADDITION”)
44. REVIEW ALL ANTI-INFLAMMATORY MEDICATIONS,
BENEFITS/RISKS, PATIENT EDUCATION, ALTERNATIVES FOR DRUG 47 – 49
ALLERGIES. (PP. 850-868; KEY SEARCH TERM: “COX-2 IN THE THE”)
45. UNDERSTAND RISKS FOR ELDERLY. (PP. 853, 855, 867; KEY SEARCH
49
TERM: “RISK OF ULCERATION INCLUDE”)
46. HOW DO YOU MINIMIZE CV RISK? (P. 854; KEY SEARCH TERM:
49
“CARDIOVASCULAR EVENTS IN CONTRAST”)
47. REVIEW DUCTUS ARTERIOSUS – HOW DO YOU TREAT THIS? (PP. 780,
854, 856, 859, 867; KEY SEARCH TERM: “DUCTUS ARTERIOSUS 49 – 50
ALTHOUGH”)
48. WHAT ARE SOME ALTERNATIVES FOR PATIENTS ALLERGIC TO
ASA? (PP. 854 AND 867; KEY SEARCH TERM: “ASPIRIN USERS 50
REACTIONS”)
49. REVIEW THE SIDE EFFECTS OF THE ANTI-INFLAMMATORIES. (P. 50
853; KEY SEARCH TERM: “GASTRIC DISTRESS HEARTBURN)
50. HISTORY OF GI BLEED/GASTRITIS AND ARTHRITIS – WHAT ANTI-
INFLAMMATORY IS SAFEST? (PP. 861, 867; KEY SEARCH TERM: 50
“USING CELECOXIB INSTEAD”)
51. FAMILIARIZE YOURSELF WITH BISPHOSPHONATES, UNDERSTAND
INDICATIONS, WHEN THEY ARE CONTRAINDICATED, SIDE EFFECTS. 51
(P. 902; KEY SEARCH TERM: “ANALOGS OF PYROPHOSPHATE”)
52. KNOW HOW TO MONITOR THE SIDE EFFECTS FOR THESE DRUGS.
51 – 52
(P. 916; KEY SEARCH TERM: “ADEQUATE TOO”)
53. REVIEW MEDICATIONS, RISKS/BENEFITS, CONTRAINDICATIONS,
52 – 54
PATIENT EDUCATION. (P. 891; KEY SEARCH TERM: “GOUT GOUT IS”)
54. WHAT ARE THE DRUGS OF CHOICE FOR TREATMENT FOR ACUTE
54
GOUT? (P. 891; KEY SEARCH TERM: “ARTHRITIS NSAIDS”)
55. WHAT LABS NEED TO BE REVIEWED PRIOR TO THE USE OF THESE
54
MEDICATIONS? (WHERE IS THIS INFORMATION IN THE TEXT?)
56. REVIEW THE POPULAR DMARDS USED IN LONG TERM DRUG
THERAPY. (P. 881; KEY SEARCH TERM: “NOTED THE 55 – 56
NONBIOLOGIC”)
57. FIRST-LINE MEDICATIONS, HALF-LIFE. (P. 880; KEY SEARCH TERM:
57
“EARLY WITHIN 3”)
58. CONTRAINDICATIONS FOR USE OF MEDICATION. (PP. 881, 889; KEY 57



4